Pure Global

"Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens - Taiwan Registration 788ccb815a5bc079db05a054fd333656

Access comprehensive regulatory information for "Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 788ccb815a5bc079db05a054fd333656 and manufactured by Johnson & Johnson Surgical Vision, Inc.;; AMO Groningen B.V.. The authorized representative in Taiwan is AMO ASIA LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Johnson & Johnson surgical Vision, Inc.;; AMO PUERTO RICO MANUFACTURING, INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1 Competitors
1 Recent Registrations
788ccb815a5bc079db05a054fd333656
Registration Details
Taiwan FDA Registration: 788ccb815a5bc079db05a054fd333656
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens
TW: โ€œ็œผๅŠ›ๅฅโ€ๆทป่ฆ–ๆ˜Žๆ–ฐ่ฆ–ๅปถๆ•ฃๅ…‰็Ÿฏๆญฃๅ–ฎ็‰‡ๅž‹ไบบๅทฅๆฐดๆ™ถ้ซ”
Risk Class 3

Registration Details

788ccb815a5bc079db05a054fd333656

DHA05602694909

Company Information

Product Details

For details, it is Chinese approved copy of the imitation order

M Ophthalmology

M.3600 Artificial Crystal

import

Dates and Status

Jan 22, 2015

Jan 22, 2030

Companies Making Similar Products
Top companies providing products similar to ""Eye Care" adds vision to the new vision and astigmatism to correct the monolithic intraocular lens"